Drug recall · December 28, 2016
Lamotrigine Orally Disintegrating Tablets recall
Why: Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA
- Lots / codes
Lot Number 502240, expiry date 11/2017
- Quantity
- 3,074 boxes (30 count boxes)
- Company
- Impax Laboratories, Inc., Hayward, CA
- Distribution
- Distributed Nationwide
- Initiated
- August 19, 2016 · Voluntary: Firm initiated
- Classified
- December 22, 2016
- Reported
- December 28, 2016
- Ended
- June 1, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lamotrigine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.